Bridgebio Pharma Inc (BBIO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bridgebio Pharma Inc   (NASDAQ: BBIO)


Bridgebio Pharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bridgebio Pharma Inc's ROI in the second quarter of 2026?
Bridgebio Pharma Inc recorded a cumulative net loss of $-702 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -120.34%.

Within the Healthcare sector 620 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2254 to 3974.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -20.21 % 9 % 16.04 % 38.96 % 25.5 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 316 566 659 792 904
Return On Investment (TTM) -120.34 % -99.93 % -95.03 % -101 % -107.37 %
BBIO's Overall Ranking # 3974 # 2254 # 3484 # 3581 # 3411
Seq. Investment Change TTM -20.13 % -5.3 % -3.31 % 9.1 % 9.12 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -702 -730 -733 -806 -785

BBIO Company Profile >> Back to BBIO Roi Comparisons >> See Annual BBIO Return On Investment



Return On Investment BBIO's Ranking
Within: No.
Industry # 281
Sector # 621
Overall # 3974

Return On Investment Statistics
High Average Low
-33.04 %
-51 %
-96.08 %
(Jun 30 2020)   (Jun 30 2026)







Financial Statements
Bridgebio Pharma Inc's II. Quarter Investments $ 316 Millions BBIO's Balance sheet
Bridgebio Pharma Inc's II. Quarter Income $ -156 Millions Quarterly BBIO's Income Statement
BBIO's Income by Division See BBIO's Income by Division


BBIO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 659 775 413 514 878
Y / Y Investment Growth -14.93 % 87.5 % -19.67 % -41.38 % 318.31 %
Net Income in Millions -733 -543 -653 -485 -586
Y / Y Net Income Growth - - - - -
Annual Return On Investment -111.18 % -70.11 % -158.06 % -94.2 % -66.82 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BBIO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BBIO's Competitors
Subscribers only: Roi for Bridgebio Pharma Inc's Suppliers
Subscribers only: Return On Investment for BBIO's Customers

Other Ratios
BBIO's Roa BBIO's Inventory Turnover Ratio BBIO's Growth Rates BBIO's Dividend Statistics
BBIO's Profitability Ratios BBIO's Asset Turnover Ratio BBIO's Dividend Growth
BBIO's Roe BBIO's Valuation Ratios BBIO's Financial Strength Ratios BBIO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:36:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.